Potential noninvasive test for Alzheimer's disease

September 6, 2017
Professor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan. Credit: University of Central Lancashire

In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.

Following this breakthrough discovery, Alzheimer's sufferers may now have an additional test to improve the accuracy of in order to better tailor appropriate treatment. The research also offers a valuable opportunity to monitor the .

The study, published today in the prestigious journal Proceedings of the National Academy of Sciences, used sensor-based technology with a diamond core to analyse approximately 550 . By passing light through the diamond and observing its interactions with the blood plasma, researchers were able to identify specific chemical bonds within the blood. This biochemical data was then used to assess whether the samples were normal or contained any trace of a neurodegenerative disease, and if so, which kind.

The groundbreaking scientific investigation was carried out by researchers at the University of Central Lancashire (UCLan), in collaboration with the University of Manchester, Lancaster University and the Federal University of Rio Grande do Norte, Brazil.

Alzheimer's diagnosis currently involves careful medical evaluation including a series of brain scans, physical examinations and memory testing, yet the only conclusive diagnosis is determined by post-mortem examination. This new blood test offers a non-invasive, more accurate and relatively cost-effective method of diagnosis, which will ensure the correct management of the condition.

Professor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan, said: "We have an aging population, meaning that the incidence and prevalence of Alzheimer's is increasing, as is the need for accurate diagnosis. The ability to identify different neurodegenerative diseases through the analysis of offers a faster and accurate way of establishing the most effective treatment plan as well as disease monitoring."

This new approach could also offer potential for carrying out tests to identify and monitor early signs of , meaning that the onset of Alzheimer's and other types of neurodegenerative diseases could be detected early and intervention measures could be put in place earlier to slow the progress of these diseases. This could be particularly beneficial in the sporting world, to assess footballers, rugby players and boxers post-injury, as well as the general public.

Professor Martin added: "For those suffering with Alzheimer's disease, the damage is already well advanced once conventionally diagnosed, but this new method offers a potentially effective early screening tool when patients are only demonstrating signs of mild cognitive impairment. This is a potentially significant breakthrough for the prevention of different debilitating and chronic neurological diseases."

Explore further: Research holds promise for Alzheimer's diagnostic blood test

More information: Maria Paraskevaidi et al. Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1701517114

Related Stories

Research holds promise for Alzheimer's diagnostic blood test

April 5, 2016
University of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test.

Blood test for Alzheimer's: Study identifies procedure that detects early stages

May 4, 2011
(Medical Xpress) -- A new blood test that will diagnose Alzheimer's disease may soon hit the market, thanks to an innovative study from the Research Institute of the McGill University Health Centre (MUHC). Their findings ...

Artificial intelligence may aid in Alzheimer's diagnosis

July 6, 2016
Machine learning is a type of artificial intelligence that allows computer programs to learn when exposed to new data without being programmed. Now, researchers in The Netherlands have coupled machine learning methods with ...

Psychiatric disorders do not increase risk of Alzheimer's disease

April 4, 2017
Psychiatric disorders do not increase the risk of Alzheimer's disease, according to a recent study from the University of Eastern Finland. However, the prevalence of psychiatric diagnoses increased before the Alzheimer's ...

Recommended for you

Thinking 'out-of-the-box' may build a better brain and prevent dementia

September 25, 2017
More than 5 million Americans today are affected by Alzheimer's disease (AD). If nothing is done to stop this upward trajectory, there will be more than 16 million people with AD in the United States and more than 60 million ...

Multi-gene test predicts Alzheimer's better than APOE E4 alone

September 22, 2017
A new test that combines the effects of more than two dozen genetic variants, most associated by themselves with only a small risk of Alzheimer's disease, does a better job of predicting which cognitively normal older adults ...

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

September 20, 2017
Nearly a quarter century ago, a genetic variant known as ApoE4 was identified as a major risk factor for Alzheimer's disease—one that increases a person's chances of developing the neurodegenerative disease by up to 12 ...

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.